Literature DB >> 9545093

Correlated heart/limb anomalies in Mendelian syndromes provide evidence for a cardiomelic developmental field.

G N Wilson1.   

Abstract

Coordinated development of heart and limbs is suggested by a review of human abortus, chromosomal, and teratogenic syndromes, and characterized by an analysis of Mendelian disorders that affect the limbs, heart, or both (672, 202, or 107, respectively). Mendelian syndromes with altered limb patterns often include cardiac anomalies, as shown by limb duplications (34%), deficiencies (30%), hypoplasias (23%), or dysplasias (9.3%). Syndromes with particular cardiac anomalies, illustrated by VSD (85%) or ASD (90%), frequently include limb defects. Positional correlations of anterior (preaxial/conotruncal), posterior (postaxial/atrial), or lateral (mirror hand/atrial isometry) heart/limb anomalies are consistent with the existence of a cardiomelic developmental field. Vertebrate comparisons suggest an early D-V limb-heart gradient, influenced by the neural crest, with distal limb segments (80% of syndromic defects) at its dorsal extreme. The proposed cardiomelic field relates the genetic heterogeneity of disorders such as Holt-Oram syndrome to a cascade of molecules, including the brachyury, sonic hedgehog, bone morphogenetic protein, retinoic acid receptor, and transforming growth factor-beta families.

Entities:  

Mesh:

Year:  1998        PMID: 9545093

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Heart or hand? Unmasking the basis for specific Holt-Oram phenotypes.

Authors:  M D Schneider; R J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Bilateral infraoptic origin of anterior cerebral arteries: a rare anomaly and its embryological and clinical significance.

Authors:  S Chakraborty; N F Fanning; S K Lee; K G Terbrugge
Journal:  Interv Neuroradiol       Date:  2006-07-31       Impact factor: 1.610

3.  Isl1Cre reveals a common Bmp pathway in heart and limb development.

Authors:  Lei Yang; Chen-Leng Cai; Lizhu Lin; Yibing Qyang; Christine Chung; Rui M Monteiro; Christine L Mummery; Glenn I Fishman; Anna Cogen; Sylvia Evans
Journal:  Development       Date:  2006-04       Impact factor: 6.868

4.  Distal femoral duplication and fibular agenesis associated with congenital cardiac defect.

Authors:  Murat Cakir; Lies H Hoefsloot; Fazil Orhan; Yusuf Gedik; Figen Celep; Aysenur Okten
Journal:  Indian J Pediatr       Date:  2009-12-11       Impact factor: 1.967

5.  Restraint of Fgf8 signaling by retinoic acid signaling is required for proper heart and forelimb formation.

Authors:  Mollie R Johnson Sorrell; Joshua S Waxman
Journal:  Dev Biol       Date:  2011-07-22       Impact factor: 3.582

6.  Unusual hand malformations with cardiac defects--a variant of heart--hand syndrome IV.

Authors:  M N Muranjan; B A Bharucha
Journal:  Indian J Pediatr       Date:  2000-05       Impact factor: 1.967

7.  Hoxb5b acts downstream of retinoic acid signaling in the forelimb field to restrict heart field potential in zebrafish.

Authors:  Joshua S Waxman; Brian R Keegan; Richard W Roberts; Kenneth D Poss; Deborah Yelon
Journal:  Dev Cell       Date:  2008-12       Impact factor: 12.270

Review 8.  The pre-Mendelian, pre-Darwinian world: shifting relations between genetic and epigenetic mechanisms in early multicellular evolution.

Authors:  Stuart A Newman
Journal:  J Biosci       Date:  2005-02       Impact factor: 2.795

9.  A heart-hand syndrome gene: Tfap2b plays a critical role in the development and remodeling of mouse ductus arteriosus and limb patterning.

Authors:  Feng Zhao; Anja-Katrin Bosserhoff; Reinhard Buettner; Markus Moser
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

10.  Holt-Oram syndrome in two generations with translocation t(9;15)(p12;q11.2).

Authors:  Ahmed Okay Caglayan; Esad Koklu; Cetin Saatci; Tamer Gunes; Yusuf Ozkul; Nazmi Narin; Ali Baykan; Munis Dundar; Derya Buyukkayhan
Journal:  Ann Saudi Med       Date:  2008 May-Jun       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.